Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart...

Area of Science:

• Cardiology
• Preventive Medicine
• Biostatistics

Background:

• Growing interest in novel cardiovascular disease (CVD) risk markers necessitates standardized evaluation methods.
• Current risk assessment strategies require critical appraisal to incorporate new findings effectively.

Purpose of the Study:

• To review current concepts in CVD risk evaluation.
• To propose standards for critically appraising novel risk assessment methods.
• To guide the integration of new markers into clinical practice.

Main Methods:

• Review of current risk evaluation concepts and literature.
• Proposal of a phased approach for evaluating novel risk markers.
• Emphasis on statistical measures of discrimination and accuracy.
• Assessment of clinical utility through impact on patient management and outcomes.

Main Results:

• Adequate evaluation demands sound research design, representative populations, and sufficient outcome events.
• Novel markers must demonstrate incremental prognostic information beyond standard markers.
• Reporting should include both discrimination and accuracy measures.
• Clinical value is determined by effects on patient management and outcomes.

Conclusions:

• A multi-phase evaluation framework is proposed, from proof of concept to cost-effectiveness.
• Standardized appraisal ensures the reliable integration of novel CVD risk markers.
• Rigorous validation is crucial for improving cardiovascular disease risk prediction and patient care.